3-[(3-Chloropropyl)thio]-4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazole → HCID 67358863, 화합물
반응식
[CH3:1][N:2]1[C:7]2=[CH:8][C:9]3[CH2:15][CH2:14][NH:13][CH2:12][CH2:11][C:10]=3[CH:16]=[C:6]2[O:5][CH2:4][C:3]1=[O:17].[Cl:18][CH2:19][CH2:20][CH2:21][S:22][C:23]1[N:27]([CH3:28])[C:26]([C:29]2[O:33][CH:32]=[N:31][C:30]=2[CH3:34])=[N:25][N:24]=1>>[ClH:18].[CH3:1][N:2]1[C:7]2=[CH:8][C:9]3[CH2:15][CH2:14][N:13]([CH2:19][CH2:20][CH2:21][S:22][C:23]4[N:27]([CH3:28])[C:26]([C:29]5[O:33][CH:32]=[N:31][C:30]=5[CH3:34])=[N:25][N:24]=4)[CH2:12][CH2:11][C:10]=3[CH:16]=[C:6]2[O:5][CH2:4][C:3]1=[O:17]참가 물질
3
실험 절차
The title compound was prepared in analogy to General Procedure 1 from 4-methyl-4,6,7,8,9,10-hexahydro[1,4]oxazino[2,3-h][3]benzazepin-3(2H)-one (37 mg) and 3-[(3-chloropropyl)thio]-4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazole and was obtained as a faint yellow slightly sticky solid (45 mg).
출처 및 근거
- ORD 기록
- ord-dea4467f88f0437aa3c22ecfabf37c9a
- 출처 데이터셋
- uspto-grants-2011_08